Michael S. Lee - 14 Jul 2025 Form 4 Insider Report for Shattuck Labs, Inc. (STTK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Jul 2025, 21:01:32 UTC
Prior SEC filing
02 Jul 2025
Next SEC filing
14 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Lee

Key filing fact

Michael S. Lee filed Form 4 for Shattuck Labs, Inc. (STTK) on 16 Jul 2025.

Key facts

  • This page summarizes Michael S. Lee's Form 4 filing for Shattuck Labs, Inc. (STTK).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 16 Jul 2025, 21:01.

Change

  • Previous filing in this sequence was filed on 02 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001748010 Primary reporting owner

Lee Michael Stewart

Relationship
Director
Address
C/O REDMILE GROUP, LLC, ONE LETTERMAN DR., BLDG. D, SUITE D3-300, SAN FRANCISCO
Signature
/s/ Michael Lee
Signature date
16 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STTK transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+33,150
Change %
Price
$0.000000
Shares after
33,150
Date
14 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
33,150
Exercise price
$0.8200
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This option represents a right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) immediately prior to the next annual meeting of the Issuer's shareholders, subject to the Reporting Person's continued service to the Issuer through such date.

Footnote F2

The stock option was granted to Mr. Lee, a managing director of Redmile Group, LLC ("Redmile"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Footnote F3

The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC remarks

Mr. Lee was elected to the board of directors of the Issuer as a representative of Redmile and its affiliates. As a result, Redmile and Mr. Green are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .